What's new

Govt to buy 7 crore J&J vaccine shots

Black_cats

SENIOR MEMBER
Dec 31, 2010
7,295
-5
10,838
Published on 12:00 AM, June 22, 2021
Govt to buy 7 crore J&J vaccine shots

Jabs to be available a year from now; enough to inoculate 60pc of adult population

Mohammad Al-Masum Molla
Bangladesh is going to purchase seven crore doses of the Johnson & Johnson's coronavirus vaccine using the Covid-19 Vaccines Global Access (Covax) facility.

The government has, in principle, decided to procure the single-dose Johnson & Johnson vaccine, called Janssen, which will be available from next June, said officials.

"A few days ago, Covax wrote to us asking whether we want Moderna or Johnson & Johnson vaccine from June next year. We decided to procure the Johnson & Johsnon vaccine as it is single dose," Health Minister Zahid Maleque told The Daily Star yesterday.

He also said that the vaccine will be purchased using the Asian Development Bank (ADB) fund.
If 12 crore people are targeted for vaccination, the seven crore doses will cover around 60 percent of the total population.

The Covax facility is a global initiative coordinated by the World Health Organization, the Vaccine Alliance Gavi, and the Coalition for Epidemic Preparedness Innovations. The facility is working to ensure that low- and middle-income countries have equitable access to Covid-19 vaccines.

The minister said they will reply to Covax, confirming the government's decision by today or tomorrow.

"We will not take Moderna vaccine due to cold chain difficulties," he added.

The Directorate General of Drug Administration (DGDA) issued an emergency use authorisation (EUA) for Johnson & Johnson's Covid-19 vaccine in the country on June 15.

It is the first single-dose Covid-19 vaccine approved for emergency use in the country. Earlier, the DGDA approved five double-dose Covid-19 vaccines for emergency use in Bangladesh.

The Janssen vaccine has indicated active immunisation against Covid-19, caused by SARS-CoV-2, in individuals aged 18 and above.

The World Health Organization, the European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America and Health Canada have already approved this vaccine for emergency use.

The Johnson & Johnson vaccine is compatible with Bangladesh's standard storage and distribution channels, as it can be stored at temperatures between 2-8°C.

The advance purchase speaks volumes of Bangladesh's desperate effort to procure vaccines from every possible source to inoculate the country's 163 million people.

Bangladesh has so far inoculated less than three percent of its population. Its vaccination campaign, which started on February 7, stumbled due to a lack of supply from the Serum Institute of India and also from Covax.
Serum Institute failed to ship the Oxford-AstraZeneca vaccines that Bangladesh purchased after cases surged in India.

As per an agreement, Bangladesh was supposed to receive three crore shots of the vaccine in phases from January to June. Serum delivered the first 50 lakh doses in January, but shipped only 20 lakh shots the following month. No shipment has been received since then. Besides, the country also received 3.3 million AstraZeneca vaccine doses as a gift from India.

Bangladesh was supposed to receive a total of 68 million vaccine doses, which would cover around 20 percent of its population, from the Covax facility this year. But it has so far received 1.06 lakh doses of the Pfizer vaccine, which was expected to be 1.09 crore by May-June.

Bangladesh submitted an official Expression of Interest (EOI) to Gavi last July 7, to get the vaccines from the Covax. On September 18, Gavi announced that Bangladesh was eligible to get vaccines, after which the health directorate submitted the National Vaccine Deployment Plan to Gavi on December 7.

"We need a huge amount of vaccines to inoculate our population. So, we have to procure them from various sources. Covax's offer was good and that's why agreed to procure [Johnson & Johnson's vaccine]," Zahid Maleque said.

Bangladesh suspended administering the first dose of the Covid-19 vaccine on April 26 due to a depleting stock. The vaccine registration process was also halted on May 5.

However, the government resumed administering the first dose from Saturday on a limited scale with around 11 lakh doses of Sinopharm vaccines, which the government got as a gift from China.

Besides, it has also started administering the Pfizer vaccine in Dhaka city yesterday.

But the government is yet to secure a bulk-purchase of vaccines even though negotiations for China's Sinopharm and Russia's Sputnik V vaccines have been ongoing for quite some time.
 

Black_cats

SENIOR MEMBER
Dec 31, 2010
7,295
-5
10,838
Idiots Bangladesh could have had its own vaccine. If they supported and gave the green light for the home grown version.
My concern is different. J&J is a single dose vaccine and may not be that effective. Government should have gone for mix of Moderna and J&J to the least as Moderna and Pfizer are the best in the market.
 

DalalErMaNodi

SENIOR MEMBER
May 12, 2020
4,906
6
7,879
Country
Bangladesh
Location
Kuwait
My concern is different. J&J is a single dose vaccine and may not be that effective. Government should have gone for mix of Moderna and J&J to the least as Moderna and Pfizer are the best in the market.

Moderna needs sophisticated cold chain and related infrastructure which BD lacks in most districts...


Simply out of questions.. moderna.
 

Bilal9

ELITE MEMBER
Feb 4, 2014
17,003
1
26,829
Country
Bangladesh
Location
United States
Moderna needs sophisticated cold chain and related infrastructure which BD lacks in most districts...


Simply out of questions.. moderna.
Well I don't know, Moderna claims they need a far less critical cold chain than Pfizer does. But claims and reality are two different things.

 
Last edited:

Black_cats

SENIOR MEMBER
Dec 31, 2010
7,295
-5
10,838
Moderna needs sophisticated cold chain and related infrastructure which BD lacks in most districts...


Simply out of questions.. moderna.
Like Astrazeneca, Moderna needs same temperature requirements 2 ~ 8 degree Celsius for a month but Pfizer needs -70 degree Celsius. If Bangladesh can get Asteazeneca so Moderna should not be an issue. Normal freezer can provide that temperature. Though for longer term storage Moderna needs -20 degree Celsius.

1624408347998.jpeg
 
Last edited:

Michael Corleone

ELITE MEMBER
Oct 27, 2014
9,782
-5
9,958
Country
Bangladesh
Location
Ukraine
Like Astrazeneca, Moderna needs same temperature requirements 2 ~ 8 degree Celsius for a month but Pfizer needs -70 degree Celsius. If Bangladesh can get Asteazeneca so Moderna should not be an issue. Normal freezer can provide that temperature. Though for longer term storage Moderna needs -20 degree Celsius.

View attachment 755661
Why are we even contemplating long term storage when we haven’t vaccinated more than half the country?
 

bluesky

ELITE MEMBER
Jun 14, 2016
11,148
0
12,754
Country
Bangladesh
Location
Japan
My concern is different. J&J is a single dose vaccine and may not be that effective. Government should have gone for mix of Moderna and J&J to the least as Moderna and Pfizer are the best in the market.
J&J seems to have 69% effectiveness. Since we are short of vaccines from other makers we should buy J&J though its effectiveness low.

J&J is a one-shot vaccine. This made me happy that the illiterate Health Minister need not divide the 7 crore vaccines by two. Below are some details of J&J vaccines:

Johnson & Johnson’s Janssen COVID-19 Vaccine:  The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) recommend that use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine resume in the United States, effective April 23, 2021. However, women younger than 50 years old should especially be aware of the rare risk of blood clots with low platelets after vaccination. There are other COVID-19 vaccines available for which this risk has not been seen.
 

Atlas

SENIOR MEMBER
Aug 2, 2018
4,413
3
4,854
Country
Bangladesh
Location
Bangladesh
J&J seems to have 69% effectiveness. Since we are short of vaccines from other makers we should buy J&J though its effectiveness low.

J&J is a one-shot vaccine. This made me happy that the illiterate Health Minister need not divide the 7 crore vaccines by two. Below are some details of J&J vaccines:

Johnson & Johnson’s Janssen COVID-19 Vaccine:  The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) recommend that use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine resume in the United States, effective April 23, 2021. However, women younger than 50 years old should especially be aware of the rare risk of blood clots with low platelets after vaccination. There are other COVID-19 vaccines available for which this risk has not been seen.
But this article suggests that the vaccine is most successful against new variants. 81 % to 87% .

 

bluesky

ELITE MEMBER
Jun 14, 2016
11,148
0
12,754
Country
Bangladesh
Location
Japan
But this article suggests that the vaccine is most successful against new variants. 81 % to 87% .

Please send an international source instead of local newspaper sources.
 

bluesky

ELITE MEMBER
Jun 14, 2016
11,148
0
12,754
Country
Bangladesh
Location
Japan
You can search Google for more.

"In a large Phase 3 trial, the J&J vaccine protected against severe/critical COVID-19 in 86% of recipients in the United States, 88% of those in Brazil and 82% of those in South Africa".

Your information says J&J is effective in 86% of cases. However, it also says it protects the human body from many variants of COVID.

So, it must be very good and in that case, the govt decision to innoculate a large number of the population with this vaccine is a good decision as Indian variation has also entered BD.
 

Black_cats

SENIOR MEMBER
Dec 31, 2010
7,295
-5
10,838
"In a large Phase 3 trial, the J&J vaccine protected against severe/critical COVID-19 in 86% of recipients in the United States, 88% of those in Brazil and 82% of those in South Africa".

Your information says J&J is effective in 86% of cases. However, it also says it protects the human body from many variants of COVID.

So, it must be very good and in that case, the govt decision to innoculate a large number of the population with this vaccine is a good decision as Indian variation has also entered BD.
For Pfizer and Moderna the rate is around 100% for severe/critical COVID-19.

Which one you have obtained in Japan?
 

bluesky

ELITE MEMBER
Jun 14, 2016
11,148
0
12,754
Country
Bangladesh
Location
Japan
For Pfizer and Moderna the rate is around 100% for severe/critical COVID-19.

Which one you have obtained in Japan?
For me, it is Pfizer. 1st shot on July 4 (Sunday) and the 2nd shot on July 25 (Sunday). Previously, there were age barriers. Now, it is a little different because the govt is in a hurry. For example, medical teams will visit big companies and innoculate the company employees there whatever their ages are.

Otherwise, Japan is very systematic unlike our Health Minister and his employees. I hope you will be interested to read the following:

1) Every citizen living in a certain City/Town has been (or will be) sent detailed information and given a Reference Number by the Health Department of that City or Town.
2) A Free Dial Number is given. When calling it to register the dates of inoculation, you have to identify yourself with the Reference Number.
3) The names of hospitals and clinics are listed on a separate page. You have to tell the phone receiver at free dial which one would you like to visit. Note that not all hospitals or clinics have been selected.

You may ask our great Health Minister to replace our non-systematic peasant system with a little better system based on discipline.
 
Last edited:

Users Who Are Viewing This Thread (Total: 1, Members: 0, Guests: 1)


Top Bottom